Ap. Jeanjean et al., IS THE SIGMA(2) RECEPTOR IN RAT-BRAIN RELATED TO THE K-III ANTIARRHYTHMIC DRUGS( CHANNEL OF CLASS), European journal of pharmacology, 241(1), 1993, pp. 111-116
The sigma2 receptor subtype was studied in rat cerebral cortex and in
C6 glioma cells homogenates using various compounds including class II
I antiarrhythmic drugs. The characteristics of )-[H-3]-3-(3-hydroxyphe
nyl)-N-(1-propyl)piperidine ((+)-[H-3]-3-PPP) binding were assessed in
competition experiments with different displacers which revealed the
presence of sigma2 receptors. Various class III antiarrhythmic drugs i
nhibited (+)-[H-3]-3-PPP binding with high affinity and their binding
affinity was found to correlate with the potency of these compounds to
increase the duration of action potentials measured in Purkinje fiber
s in electrophysiological studies. Since class III antiarrhythmic drug
s are known to interact with voltage-dependent K+ channels, the presen
t results provide evidence that the (+)-[H-3]-3-PPP binding sites in r
at brain possess the characteristics of K+ channels of class III antia
rrhythmic drugs.